Idelalisib

In this article, we will discuss Idelalisib (Dosage Overview). So, let's get started. Indications Relapsed Chronic Lymphocytic Leukemia Idelalisib is indicated, in combination with rituximab, for the treatment of patients with relapsed chronic lymphocytic leukemia (CLL) for whom rituximab alone would be considered appropriate therapy due to other co-morbidities. Relapsed Follicular B-cell non-Hodgkin Lymphoma Idelalisib … Continue reading Idelalisib